engleski

Management of heparin-induced thrombocytopenia with fondaparinux in a patient with left ventricular assist device

Heparin-induced thrombocytopenia is an immune- mediated serious adverse effect of heparin therapy. It is a relatively frequent complication among patients with mechanical circulatory support. Herein, we present a patient with severe heart failure and sepsis who developed heparin- induced thrombocytopenia shortly after implantation of left ventricular assist device as a bridge to transplantation and who was successfully treated with fondaparinux.

heart failure ; heparin-induced thrombocytopenia ; sepsis ; ventricular assist device ; anticoagulation

nije evidentirano